DK0476113T3 - Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose - Google Patents

Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose

Info

Publication number
DK0476113T3
DK0476113T3 DK91907526.7T DK91907526T DK0476113T3 DK 0476113 T3 DK0476113 T3 DK 0476113T3 DK 91907526 T DK91907526 T DK 91907526T DK 0476113 T3 DK0476113 T3 DK 0476113T3
Authority
DK
Denmark
Prior art keywords
atherosclerosis
treatment
pct
hyperlipidemia
drug
Prior art date
Application number
DK91907526.7T
Other languages
English (en)
Inventor
Hans-Ludwig Schaefer
Werner Schneider
Original Assignee
Steigerwald Arzneimittelwerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk filed Critical Steigerwald Arzneimittelwerk
Application granted granted Critical
Publication of DK0476113T3 publication Critical patent/DK0476113T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DK91907526.7T 1990-04-06 1991-04-06 Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose DK0476113T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4011285A DE4011285A1 (de) 1990-04-06 1990-04-06 Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose

Publications (1)

Publication Number Publication Date
DK0476113T3 true DK0476113T3 (da) 1996-07-15

Family

ID=6403968

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91907526.7T DK0476113T3 (da) 1990-04-06 1991-04-06 Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose

Country Status (17)

Country Link
US (1) US5434141A (da)
EP (1) EP0476113B1 (da)
JP (1) JPH05500673A (da)
KR (1) KR920700656A (da)
AT (1) ATE135223T1 (da)
AU (1) AU639097B2 (da)
CA (1) CA2063588A1 (da)
DE (2) DE4011285A1 (da)
DK (1) DK0476113T3 (da)
ES (1) ES2086538T3 (da)
GR (1) GR3019866T3 (da)
HU (1) HU218925B (da)
LT (1) LT3543B (da)
LV (1) LV10839B (da)
RU (1) RU2108788C1 (da)
UA (1) UA35566C2 (da)
WO (1) WO1991015214A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6084067A (en) * 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US6824779B1 (en) 1993-07-26 2004-11-30 Dana-Farber Cancer Institute, Inc. Methods for inhibiting the interaction of B7-2 with its natural ligand
JPH0948732A (ja) * 1995-08-04 1997-02-18 Pola Chem Ind Inc 活性酸素消去剤及びそれを含む組成物
US6929807B1 (en) 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
EP0923382B1 (en) * 1996-08-09 2002-05-29 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US5942500A (en) * 1998-04-27 1999-08-24 Perry; Stephen C. Dietary composition to reduce dietary fats
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
JP4488852B2 (ja) * 2004-09-17 2010-06-23 味の素ゼネラルフーヅ株式会社 体内脂肪低減作用を有する組成物
WO2008011216A2 (en) 2006-05-16 2008-01-24 Pro-Pharmaceuticals, Inc. Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
WO2012138213A1 (en) * 2011-04-08 2012-10-11 N.V. Nutricia Reduction of vascular dysfunction with specific saccharides
WO2013040316A1 (en) 2011-09-16 2013-03-21 Galectin Therapeutics, Inc. Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
WO2013184892A1 (en) 2012-06-06 2013-12-12 Galectin Therapeutics, Inc. Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase
RU2523886C1 (ru) * 2013-06-21 2014-07-27 Борис Львович ВИНОКУРОВ Способ профилактики и лечения нарушений обмена веществ по типу липидемии в сочетании с инсулиннезависимым сахарным диабетом методом питьевой бальнеотерапии с использованием природной минеральной галогенсодержащей воды

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2370961A (en) * 1941-11-15 1945-03-06 Rohm & Haas Preparation of alpha-d-galacturonic acid
DE2036605A1 (de) * 1970-07-23 1972-05-31 Mylaeus, Armin, 5970 Plettenberg Diätbrot und Verfahren zu seiner Herstellung
DE2521765B2 (de) * 1975-05-16 1979-01-18 Valentin Dr.Med. Koehler Verwendung von D-Glucuronsäure, dessen γ -Lacton, Galacturonsäure oder Mannuronsäure
GB1549501A (en) * 1976-06-03 1979-08-08 Mora E Adducts of vincamine and apovincamine
JPS54119038A (en) * 1978-03-07 1979-09-14 Takeda Chemical Industries Ltd Digestion difficult polysaccaride containing food
FR2449452A1 (fr) * 1978-11-15 1980-09-19 Krauter Henri Nouveau medicament utile notamment comme diuretique et detoxicant, derive de l'acide galacturonique
JPS59206045A (ja) * 1983-05-11 1984-11-21 Asahi Chem Ind Co Ltd 低比重リポ蛋白質吸着材
DD271415A3 (de) * 1983-07-05 1989-09-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines pektindiaetetikums
US4617276A (en) * 1985-01-23 1986-10-14 Agway Inc. Novel method for quantitating structural and non-structural carbohydrates in feedstuffs
US4615891A (en) * 1985-01-23 1986-10-07 Agway Inc. Method of formulating dairy cow rations based on carbohydrate regulation
US5063210A (en) * 1989-04-20 1991-11-05 Lange Iii Louis G Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
DK81690D0 (da) * 1990-03-30 1990-03-30 Grindsted Prod As Pektinprodukt og fremgangsmaade til fremstilling deraf

Also Published As

Publication number Publication date
AU639097B2 (en) 1993-07-15
RU2108788C1 (ru) 1998-04-20
ES2086538T3 (es) 1996-07-01
GR3019866T3 (en) 1996-08-31
KR920700656A (ko) 1992-08-10
UA35566C2 (uk) 2001-04-16
LV10839A (lv) 1995-10-20
ATE135223T1 (de) 1996-03-15
LTIP1534A (en) 1995-06-26
AU7664991A (en) 1991-10-30
HUT61199A (en) 1992-12-28
US5434141A (en) 1995-07-18
DE4011285A1 (de) 1991-10-10
EP0476113A1 (de) 1992-03-25
CA2063588A1 (en) 1991-10-07
JPH05500673A (ja) 1993-02-12
WO1991015214A1 (de) 1991-10-17
LV10839B (en) 1996-04-20
HU913814D0 (en) 1992-04-28
EP0476113B1 (de) 1996-03-13
HU218925B (hu) 2000-12-28
LT3543B (en) 1995-11-27
DE59107536D1 (de) 1996-04-18

Similar Documents

Publication Publication Date Title
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
DE3850492D1 (de) Chirurgisches bewässerungs- und absaugesystem.
DK617189A (da) Anvendelse af bis(3,5-di-t-butyl-4-hydroxy-phenylthio)-methan til fremstilling af et laegemiddel mod atherosclerose og hypercholesterolaemi
NO930615D0 (no) Hypoglykemiske hydroksyurinstoffderivater
DE68913638D1 (de) Behandlung von wässerigen Systemen.
NO910687L (no) Fremgangsmaate for fremstilling av et stabilt soetningsmiddel-utleveringssystem og tyggegummi.
NO922949L (no) Forbindelser og fremgangsmaater for inhibering av hiv- og beslektede virus
NO922936L (no) Fremstilling av fettsyremedikamenter
ATE135223T1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
NO894845D0 (no) Fremgangsmaate og materialer for mikrobiell bioomdannelse av toluen og andre fenylforbindelser.
DE3763507D1 (de) Patientenlagerungstisch.
TW261532B (da)
DE3785459D1 (de) Abtrennvorrichtung eines blutbestandteiles.
DE68912670D1 (de) Behandlung von Celluloseblättern.
NO881510D0 (no) Sterilt formeringssystem.
DE3763140D1 (de) Patientenlagerungstisch.
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DK591787A (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
DE3685177D1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
DK160821C (da) 1,3-dihydro-4-benzoyl-2h-imidazol-2-oner samt middel til behandling af hjertesvigt
SE9403861D0 (sv) Novel medicinal use
IT8522420A0 (it) Ginocchiera medicale.
NO901892D0 (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.